Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rubin

Showing results (1141-1150 of 1,437) with videos related to

Pageof 144
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implicationsJuan-Miguel Mosquera, Sven Perner, Elizabeth M Genega, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Oncogene-mediated alterations in chromatin conformationDavid S Rickman, T David Soong, Benjamin Moss, et al.
Nature Communications|November 19, 2021
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancerChandrani Mukhopadhyay, Chenyi Yang, Limei Xu, et al.
The Review of Scientific Instruments|December 2, 2021
A dynamic collimation and alignment system for the Helmholtz linear acceleratorS Lauber, K Aulenbacher, W Barth, et al.
Cancer Research|December 13, 2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progressionPei-Chun Lin, Ya-Lin Chiu, Samprit Banerjee, et al.
Oncogene|July 30, 2013
Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2N K Mukhopadhyay, J Kim, S You, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
The Journal of Urology|October 16, 2007
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalitiesScott E Eggener, Peter T Scardino, Peter R Carroll, et al.
Nature|October 11, 2002
The polycomb group protein EZH2 is involved in progression of prostate cancerSooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, et al.
The Journal of Urology|February 19, 2008
A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA ConsortiumChris Mullins, M Scott Lucia, Simon W Hayward, et al.
Pageof 144

Showing results (1141-1150 of 1,437) with videos related to

Sort By:
Pageof 144
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implicationsJuan-Miguel Mosquera, Sven Perner, Elizabeth M Genega, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2012
Oncogene-mediated alterations in chromatin conformationDavid S Rickman, T David Soong, Benjamin Moss, et al.
Nature Communications|November 19, 2021
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancerChandrani Mukhopadhyay, Chenyi Yang, Limei Xu, et al.
The Review of Scientific Instruments|December 2, 2021
A dynamic collimation and alignment system for the Helmholtz linear acceleratorS Lauber, K Aulenbacher, W Barth, et al.
Cancer Research|December 13, 2012
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progressionPei-Chun Lin, Ya-Lin Chiu, Samprit Banerjee, et al.
Oncogene|July 30, 2013
Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2N K Mukhopadhyay, J Kim, S You, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
The Journal of Urology|October 16, 2007
Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalitiesScott E Eggener, Peter T Scardino, Peter R Carroll, et al.
Nature|October 11, 2002
The polycomb group protein EZH2 is involved in progression of prostate cancerSooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, et al.
The Journal of Urology|February 19, 2008
A comprehensive approach toward novel serum biomarkers for benign prostatic hyperplasia: the MPSA ConsortiumChris Mullins, M Scott Lucia, Simon W Hayward, et al.
Pageof 144